Navigation Links
Schering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment
Date:11/2/2007

ORLANDO, Fla., Nov. 2 /PRNewswire-FirstCall/ -- Addressing more than 100 cardiologists and other medical experts from 24 countries, Fred Hassan, Schering-Plough chairman and CEO, set out four critical priorities for improving the current health care environment. Hassan spoke today at Schering-Plough's fourth annual Cardiovascular Summit in advance of the American Heart Association's annual Scientific Sessions 2007.

In his speech, Hassan emphasized the potential for innovations to achieve major medical progress and improved treatment outcomes. He pointed to a study published in The New England Journal of Medicine (June 7, 2007 issue) that explored the reasons behind a dramatic decrease in U.S. deaths from cardiovascular disease between 1980-2000.

Hassan also reviewed the progress of Schering-Plough's transformation, its continuing investment in R&D and the promise of its planned combination with Organon BioSciences N.V.

Addressing the broader health care environment, Hassan identified four critical areas of opportunity for improvement:

-- First, transform the quality of care;

-- Second, transform biopharma's innovation engines;

-- Third, support a strong U.S. Food and Drug Administration; and,

-- Fourth, improve access and affordability for patients.

Hassan's speech (as prepared for delivery) is available via the following link: http://www.schering-plough.com/pdf/HassanCVSummitspeech11-2-07.pdf

Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its approximately 33,500 people around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Asmanex Twisthaler launched by Schering-Plough for treatment of asthma
2. Calls to combat deafness after chemotherapy
3. WHO Calls For Greater Emphasis On Combating AIDS
4. PCT Calls Upon Doctor To Delay Surgeries
5. UN Calls For More Funds For Earthquake Affected
6. MP Calls For Ban On Aspartame
7. Scientist Calls Upon Media To Retract His Work
8. CMHA Calls For Better Trained Police For Dealing With The Mentally Ill
9. US Government Calls For Better Drug Supplies
10. Phone Calls Lend Vital Support to Moms of Mentally Ill Children
11. Report Calls For Better Implementation Of Last Wishes of Terminally Ill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
Breaking Medicine Technology: